Onconetix shareholders approve reverse stock split up to 1-for-10

Onconetix, Inc.

Reverse split proposal approved with 1,301,918 for, 253,378 against, 1,393 abstentions.
Board may implement one or more splits at ratios between 1:2 and 1:10 within one year, not exceeding 1:100 aggregate.
Adjournment proposal also approved with 1,332,088 for, 223,071 against, 1,530 abstentions.
Reverse split authorized without further stockholder approval; exact ratio to be set by the board.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Onconetix, Inc. shareholders approved Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect one or more reverse stock splits of all of the outstanding shares of the Company's common stock, par value $0.00001 per share, at a ratio in the range of 1-for-2 to 1-for-10, at any time prior to th at the 2026-04-30 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2026-04-30

Exact text from the filing

1. Reverse Stock Split Proposal The votes were cast for this matter as follows: Votes For Votes Against Abstentions 1,301,918 253,378 1,393

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Onconetix, Inc. shareholders approved Approval of the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Reverse Stock Split Proposal. at the 2026-04-30 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2026-04-30

Exact text from the filing

2. The Adjournment Proposal. The votes were cast for this matter as follows: Votes For Votes Against Abstentions 1,332,088 223,071 1,530

View on SEC.gov

543 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-051575

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.